OpenFilings

Phio Pharmaceuticals Corp.

Form10-K

Report Period2022-12-31

Date Filed2023-03-22

Time Filed17:00:34

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

FORM 10-K
CLINICAL CO-DEVELOPMENT AGREEMENT
SEPARATION AGREEMENT, DATE MAY 5, 2022, BY AND BETWEEN PHIO PHARMACEUTICALS CORP
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CERTIFICATION
CERTIFICATION
Filing on SEC Edgar